SCHEMBL4543284

SCHEMBL4543284

NS(=O)(=O)c1ccc(-c2cnns2)cc1-c1cnns1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 2/20 0.45
RUNX1 Q01196 2/20 0.45
CBFB Q13951 2/20 0.45
GFER P55789 1/20 0.45
ALOX5AP P20292 5/20 0.36
FEN1 P39748 5/20 0.36
PTGS2 P35354 6/20 0.33
PTGS1 P23219 2/20 0.33
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
ACVR1 Q04771 1/20 0.32
CA14 Q9ULX7 1/20 0.32
LRRK2 Q5S007 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16718782 0.83 ALOX5AP (0.41) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL1094712 0.80 ALDH1A1 (0.45) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL6622014 0.78 CNR1 (0.42) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL14921415 0.76 CA2 (0.52) PTGS2PTGS1CA12CA1CA2
SCHEMBL6626712 0.74 ALDH1A1 (0.40) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL2659243 0.73 ALDH1A1 (0.45) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL5762682 0.72 LRRK2 (0.42) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL9135746 0.69 MAPT (0.51) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL5767070 0.69 LRRK2 (0.44) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL6622402 0.68 PTGS2 (0.44) ALDH1A1GAAMAPTHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631558-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2006-03-08 EP claimed
WO-2004113310-A1 USE OF AN INHIBITOR OF 11-B-HYDROXYSTEROID DEHYDROGENASE TYPE 1 COMPOUNDS FOR PROMOTING WOUND HEALING BIOVITRUM AB (SE) 2004-12-29 WO claimed
WO-2004103980-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2004-12-02 WO claimed
WO-2016193499-A1 IMMUNOMODULATORY ANTIBODY OR IMMUNOTHERAPEUTIC, AGENT WHICH INCREASES AND/OR MIMICKS KYNURENINE, AND OPTIONAL COMBINATION THEREOF IMMUSMOL SAS (FR) 2016-12-08 WO disclosed
EP-3082821-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions, Inc. (US) 2016-10-26 EP disclosed
WO-2015130957-A1 HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL Zalicus Pharmaceuticals, Ltd. (US) 2015-09-03 WO disclosed
WO-2015073797-A1 ANTIPARASITIC COMPOUNDS SCYNEXIS INC. (US) 2015-05-21 WO disclosed
EP-2054056-A2 SMALL MOLECULE INHIBITORS OF KYNURENINE-3-MONOOXYGENASE The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone (US) 2009-05-06 EP disclosed
WO-2008022286-A2 SMALL MOLECULE INHIBITORS OF KYNURENINE-3-MONOOXYGENASE THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE (US) 2008-02-21 WO disclosed
EP-1631558-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2006-03-08 EP disclosed
WO-2004103980-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2004-12-02 WO disclosed